Bonraybio Co., Ltd. (TPE:6955)
107.00
-13.00 (-10.83%)
Aug 26, 2026, 12:17 PM CST
Bonraybio Revenue
Bonraybio had revenue of 92.33M TWD in the quarter ending June 30, 2026, with 15.72% growth. This brings the company's revenue in the last twelve months to 332.21M, up 22.63% year-over-year. In the year 2025, Bonraybio had annual revenue of 306.31M with 37.43% growth.
Revenue (ttm)
332.21M
Revenue Growth
+22.63%
P/S Ratio
8.96
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.98B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 306.31M | 83.43M | 37.43% |
| Dec 31, 2024 | 222.88M | 63.24M | 39.61% |
| Dec 31, 2023 | 159.64M | 53.37M | 50.22% |
| Dec 31, 2022 | 106.27M | 49.98M | 88.78% |
| Dec 31, 2021 | 56.30M | 29.71M | 111.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Hi-Clearance | 4.41B |
| Wellell | 2.50B |
| OK Biotech | 1.54B |
| Dynamic Medical Technologies | 1.40B |
| WeLeader Biomedical | 1.21B |
| AViTA | 972.61M |
| A Plus Biotechnology | 887.93M |
| Medimaging Integrated Solution | 682.01M |